ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer.

Wei Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.